ImmunityBio (IBRX) Enterprise Value (2013 - 2026)
ImmunityBio (IBRX) reported Enterprise Value of -$380.0 million for Q1 2026, down 526.63% year-over-year from $89.1 million in Q1 2025, and down 57.07% quarter-over-quarter from -$241.9 million in Q4 2025.
ImmunityBio (IBRX) Enterprise Value (2013 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 14 years of Enterprise Value data on file, last reported at -$380.0 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$380.0 million, down 526.63% year-over-year; the trailing twelve-month figure through Mar 2026 was -$380.0 million (down 526.63% YoY), and the FY2025 annual result was -$241.9 million, down 62.54% from the prior year.
- Enterprise Value retreated to -$380.0 million in Q1 2026 per IBRX's latest filing, from -$241.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$49.0 million in Q2 2023 and troughed at -$380.0 million in Q1 2026.
- A 5-year average of -$168.0 million and a median of -$152.7 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value jumped 65.6% in 2022, then sank 526.63% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$109.7 million in 2022, then slumped by 141.99% to -$265.4 million in 2023, then soared by 43.92% to -$148.8 million in 2024, then tumbled by 62.54% to -$241.9 million in 2025, then plunged by 57.07% to -$380.0 million in 2026.
- Business Quant data shows IBRX's Enterprise Value at -$380.0 million in Q1 2026, -$241.9 million in Q4 2025, and -$256.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | -380.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -380.00 Mn |
| Dec 31, 2025 | -241.92 Mn |
| Sep 30, 2025 | -256.90 Mn |
| Jun 30, 2025 | -152.73 Mn |
| Mar 31, 2025 | -60.64 Mn |
| Dec 31, 2024 | -148.84 Mn |
| Sep 30, 2024 | -129.38 Mn |
| Jun 30, 2024 | -216.97 Mn |
| Mar 31, 2024 | -169.47 Mn |
| Dec 31, 2023 | -265.41 Mn |
| Sep 30, 2023 | -188.72 Mn |
| Jun 30, 2023 | -49.02 Mn |
| Mar 31, 2023 | -94.00 Mn |
| Dec 31, 2022 | -109.68 Mn |
| Sep 30, 2022 | -113.44 Mn |
| Jun 30, 2022 | -85.10 Mn |
| Mar 31, 2022 | -194.24 Mn |
| Dec 31, 2021 | -318.86 Mn |
| Sep 30, 2021 | -81.82 Mn |
| Jun 30, 2021 | -104.57 Mn |